Drug intelligence / Profile preview

Biyan Tong fumigation lotion

Development stage: Unknown
Lead developer: Beijing University of Chinese Medicine Shenzhen Hospital
Administration: Inhalation

Overview

Biyan Tong fumigation lotion is a Traditional Chinese Medicine (TCM) formulation developed by the Shenzhen Hospital of the Beijing University of Chinese Medicine for the treatment of allergic rhinitis. It is administered via fumigation, a delivery method where the herbal solution is heated to produce steam that is inhaled through the nasal passages. The formulation is intended to alleviate symptoms of persistent allergic rhinitis, such as nasal congestion, sneezing, and rhinorrhea, by modulating inflammatory responses and metabolic pathways in the nasal mucosa. Clinical evaluation includes a Phase 0 study focusing on its efficacy, safety, and underlying metabolomic mechanisms compared to a normal saline control.

Other names: Biyan Tong

Beyond the preview

Go deeper on Biyan Tong fumigation lotion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biyan Tong fumigation lotion.

Explore the full profile